via John Innes Centre
Researchers have taken positive steps towards using plant virus-based particles for the treatment of human autoimmune diseases such as type 1 diabetes and rheumatoid arthritis.
Viruses are natural, self-assembling nano-scale structures that have been exploited in the fields of electronics, agriculture and medicine.
The genetically encoded coat proteins of virus nanoparticles (VNPs) can be reprogrammed to incorporate new sequences for specific functions. Plant viruses have the advantage in that they are unable to replicate in mammals making them safer for medical applications.
In this study led by the University of Verona, Italy, researchers explored whether VNPs engineered to display a specific protein sequence could help to prevent or treat type 1 diabetes and rheumatoid arthritis.
They used cowpea mosaic virus (CPMV) constructs developed in the Lomonossoff lab at the John Innes Centre. These VNPs displayed peptides associated with type 1 diabetes in order to modulate immune system response. The researchers also used other VNPs, engineering tomato bushy stunt virus with peptides associated with rheumatoid arthritis.
Using animal models to analyse immune system responses, they reveal that the re-engineered nanoparticles offered therapeutic benefits in both cases: protection against type 1 diabetes and improved symptoms of rheumatoid arthritis.
More pre-clinical and clinical trials will follow up this work. If successful it could pave the way for the development of plant viruses for the clinical treatment of human autoimmune diseases.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Human autoimmune diseases
- Device protects human liver cells producing critical biomolecules for six months in mice
Biomedical engineers at Duke University have devised a pouch designed to create temporary chimeras—mixed species—to treat diseases. In a proof-of-concept study, the device protected transplanted human ...
- Farmed Carnivores May Become Hidden “Disease Reservoirs” Posing Risk to Human Health
Carnivorous animals lack key genes needed to detect and respond to infection by pathogens, a study has found. Farming large numbers of carnivores, like mink, could allow the formation of undetected ...
- Immune Cells Found to Cooperate to Fight Toxic Protein Clumps
Immune cells in the brain responsible for breaking down the toxic protein clumps, or aggregates, that lead to nerve cell death in Parkinson’s disease join together to form networks to share the burden ...
- Watch now: ISU research could help explain human autoimmune disorders
Illinois State University biology professor Nathan Mortimer speaks about how a recent paper and research from his lab could someday be used to describe autoimmune disorders in humans. READ MORE ...
- Watch now: ISU lab explores flies and autoimmune disorders
A common household pest could explain how autoimmune disorders occur in humans. A recent paper by an Illinois State University professor and past and present students helps describe how fruit ...
Go deeper with Google Headlines on:
Human autoimmune diseases
Go deeper with Bing News on:
Plant viruses
- Crisis Worsens in Romania; H.K. Waives Gym Masks: Virus Update
Moderna Inc. and Johnson & Johnson made the case for booster doses of their vaccines before a key regulatory meeting later this week.
- Leaf samples confirm 4 diseases hit cornfield
Leaf samples, which also included one ear with husks but no stalks, sent to the Purdue University Plant and Pest Diagnostic Lab confirmed the presence of not one, not two, but four diseases. The ...
- Five fungus diseases to watch for this fall
Fungi often commit their dirty and sometimes fatal deeds in the lawn and garden with the unwitting help of homeowners.
- 5 tips for fall gardening: What to plant; which pests to watch out for and more
Fall is the perfect time to plant leafy greens, including lettuces, spinach and chards, and vegetables like broccoli and brussels sprouts.
- Moderna plans to build vaccine plant in Africa to produce 500 million doses a year for lower-income nations
Biotechnology company Moderna, under intense pressure to send more of its coronavirus vaccine to lower-income countries, announced Thursday it would build a manufacturing plant in Africa capable of ...
Go deeper with Google Headlines on:
Plant viruses
